-

06:53:54 AM

LIVE Real Time VERO Stock Market News

VERO - Venus Concept Inc

04/08/21 7:30 AM

Nasdaq : VERO

Venus Concept to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021

Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced that first quarter of fiscal year 2021 financial results will be released after the market closes on Monday, May 17, 2021.

RHEA-AI

neutral

03/29/21 4:05 PM

Nasdaq : VERO

Venus Concept Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Reaffirms Fiscal Year 2021 Revenue Guidance

Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2020. Fourth Quarter 2020 Financial Summary: Total GAAP

RHEA-AI

neutral

03/25/21 7:30 AM

Nasdaq : VERO

Venus Concept Announces Global Brand Ambassador Partnership with Tennis Champion and Entrepreneur Venus Williams

Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that Venus Williams, four-time Olympic Gold Medalist, seven-time Grand Slam Champion and entrepreneur, has signed on as

RHEA-AI

very positive

03/11/21 4:05 PM

Nasdaq : VERO

Venus Concept Inc. to Participate in Two Upcoming Investor Conferences on March 17th

Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the following upcoming investor conferences in March: The Oppenheimer 31 st Annual

RHEA-AI

neutral

03/04/21 4:05 PM

Nasdaq : VERO

Venus Concept Inc. to Present at the H.C. Wainwright Annual Global LifeSciences Conference on March 9th

Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will attend and present at the H.C. Wainwright Annual Global LifeSciences Conference, which is being held

RHEA-AI

neutral

02/09/21 7:30 AM

Nasdaq : VERO

Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17th

Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference.

RHEA-AI

neutral

02/08/21 4:05 PM

Nasdaq : VERO

Venus Concept to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 29, 2021

Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced that fourth quarter and fiscal year 2020 financial results will be released after the market closes on Monday, March 29, 2021.

RHEA-AI

neutral

01/14/21 6:30 AM

Nasdaq : VERO

Venus Concept Reports Preliminary Revenue Results for Fourth Quarter 2020; Introduces Fiscal Year 2021 Revenue Guidance

Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited revenue results for the three months ended December 31, 2020 and introduced revenue guidance

RHEA-AI

neutral

01/05/21 4:05 PM

Nasdaq : VERO

Venus Concept Inc. to Present at Two Upcoming Investor Conferences in January

Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the following upcoming investor conferences in January: The H.C. Wainwright BioConnect

RHEA-AI

neutral

12/22/20 8:55 AM

Nasdaq : VERO

Venus Concept Inc. Announces Pricing of $22.5 Million Public Offering

Venus Concept Inc. ("Venus Concept" or the "Company") (Nasdaq: VERO), a global medical aesthetic technology leader, today announced the pricing of its public offering of 11,250,000 shares of its common stock and warrants to purchase 5,625,000 shares of

RHEA-AI

neutral